Ebola Vaccine Development
$0Z01FY2005AINIH
Niaid Extramural Activities
Investigators
Linked publications & trials
Paper 22560007Paper 17238286Paper 16988008Paper 16857271Paper 16683867Paper 15937495Paper 15831716Paper 15596847
Abstract
A vaccine against Ebola virus would be highly significant in preventing outbreaks which are both naturally occurring or the result of bioterrorist activity. Modifications to previously developed Ebola vaccines were made during the past year to improve expression and immunogenicity.
View original record on NIH RePORTER →